Daniel OByrne - Royce Value Vice President
| RVT Stock | USD 16.23 0.30 1.88% |
President
Mr. Daniel A. OByrne serves as Vice President of Royce Value Trust Inc., since 1994. He is Principal and Vice President of Royce, having been employed by Royce since October 1986. since 1994.
| Age | 58 |
| Tenure | 30 years |
| Address | 745 Fifth Avenue, New York, NY, United States, 10151 |
| Phone | 212 508 4500 |
| Web | https://www.roycefunds.com/funds/royce-value-trust |
Royce Value Management Efficiency
At this time, Royce Value's Return On Capital Employed is comparatively stable compared to the past year. Return On Equity is likely to gain to 0.18 in 2024, whereas Return On Tangible Assets are likely to drop 0.17 in 2024. Non Current Liabilities Total is likely to gain to about 45.2 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 21.2 M in 2024. Royce Value's management efficiency ratios could be used to measure how well Royce Value manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Thomas Fuccillo | Allianzgi Diversified Income | 52 | |
| Yigal Jhirad | Cohen And Steers | 56 | |
| Angela Borreggine | Allianzgi Diversified Income | 56 | |
| Stephen Murphy | Cohen And Steers | 54 | |
| William Scapell | Cohen And Steers | 53 | |
| Robert Becker | Cohen And Steers | 51 | |
| William Scapell | Cohen Steers Total | 53 | |
| Esq Bordewick | MFS Investment Grade | 65 | |
| Thomas Bohjalian | Cohen Steers Qualityome | 55 | |
| Stephen Murphy | Cohen Steers Qualityome | 54 | |
| Albert Laskaj | Cohen Steers Total | 43 | |
| Daniel Omstead | Tekla Life Sciences | 67 | |
| Stephen Murphy | Cohen Steers Reit | 54 | |
| Stephen Welsh | MFS Investment Grade | 67 | |
| Andrew Arnott | John Hancock Financial | 49 | |
| Jason Yablon | Cohen Steers Total | 41 | |
| Joseph Harvey | Cohen Steers Qualityome | 57 | |
| Dr MS | Tekla Life Sciences | 71 | |
| Thomas Bohjalian | Cohen Steers Reit | 55 | |
| Stephen Murphy | Cohen Steers Total | 54 | |
| Daniel Omstead | Tekla Healthcare Opportunities | 67 | |
Management Performance
| Return On Equity | 0.12 | ||||
| Return On Asset | -3.0E-4 |
Royce Value Closed Leadership Team
Elected by the shareholders, the Royce Value's board of directors comprises two types of representatives: Royce Value inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Royce. The board's role is to monitor Royce Value's management team and ensure that shareholders' interests are well served. Royce Value's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Royce Value's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Peter Hoglund, Treasurer | ||
| Charles Royce, President, Primary Portfolio Manager and Interested Director | ||
| Arthur Mehlman, Independent Director | ||
| Lisa Curcio, Chief Compliance Officer | ||
| Stephen Isaacs, Independent Director | ||
| David Meister, Independent Director | ||
| G OBrien, Independent Director | ||
| Francis Gannon, Vice President | ||
| John Denneen, Chief Legal Officer and Secretary | ||
| Cecile Harper, Independent Director | ||
| Daniel OByrne, Vice President | ||
| Michael Shields, Independent Director | ||
| Christopher Grisanti, Independent Director | ||
| Christopher Flynn, Portfolio Manager | ||
| Christopher Clark, President, Chief Executive Officer, Co-Chief Investment Officer, Managing Director | ||
| Lauren CFA, Principal Manager | ||
| Patricia Chadwick, Independent Director |
Royce Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Royce Value a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.12 | ||||
| Return On Asset | -3.0E-4 | ||||
| Profit Margin | 9.94 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 1.91 B | ||||
| Shares Outstanding | 115.35 M | ||||
| Shares Owned By Insiders | 0.06 % | ||||
| Shares Owned By Institutions | 27.43 % | ||||
| Number Of Shares Shorted | 32.42 K | ||||
| Price To Earning | 4.66 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Royce Stock Analysis
When running Royce Value's price analysis, check to measure Royce Value's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Royce Value is operating at the current time. Most of Royce Value's value examination focuses on studying past and present price action to predict the probability of Royce Value's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Royce Value's price. Additionally, you may evaluate how the addition of Royce Value to your portfolios can decrease your overall portfolio volatility.